{"id":"W2600242980","doi":"10.1200/jco.2012.30.15_suppl.1099","title":"Phase II trial of sorafenib (S) and vinorelbine (V) in metastatic breast cancer (mBC) with pharmacokinetics (PK) analysis.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Pharmacokinetics; Tolerability; Metastatic breast cancer; Vinorelbine; Internal medicine; Toxicity; Gastroenterology; Neutropenia; Urology; Pharmacology; Cancer; Breast cancer; Oncology; Chemotherapy; Adverse effect","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001032666,0.001198066,0.001565135,0.0003311369,0.0002970038,0.000795645,0.0005841856,0.001111118,0.004350731],"category_scores_gemma":[0.000833681,0.0005378695,0.0008136972,0.0003213253,0.0006023992,0.0005657481,0.0003296986,0.001869383,0.000827738],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009571521,"about_ca_system_score_gemma":0.001502407,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008297267,"about_ca_topic_score_gemma":0.001673028,"domain_scores_codex":[0.9996346,0.0001841364,0.00001509913,0.0000554319,0.00003465672,0.00007603157],"domain_scores_gemma":[0.9993972,0.0001012158,0.0001042924,0.00003935162,0.00002929243,0.0003287348],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8373663,0.03936002,0.006546377,0.0005864232,0.0008265998,0.0004814927,0.0002424904,0.002797959,0.04513093,0.0002779058,0.003603401,0.06278005],"study_design_scores_gemma":[0.5349052,0.4432856,0.01112523,0.0000298507,0.0002653512,0.0005444334,0.00005065085,0.001879686,0.004235611,0.0002236285,0.003428878,0.0000258107],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9941962,0.001461448,0.0003669375,0.0003305234,0.00008187359,0.001585996,0.0008008201,0.00006093892,0.001115252],"genre_scores_gemma":[0.990881,0.0008559528,0.000991334,0.0004843274,0.0001110781,0.001967979,0.002149429,0.00001949516,0.002539466],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004350731,"threshold_uncertainty_score":0.01455462,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1516274844059308,"score_gpt":0.5508904711779373,"score_spread":0.3992629867720066,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}